We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
401
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$3.5M 0.03%
370,000
– –
USB icon
402
US Bancorp
USB
$98B
$3.45M 0.03%
96,286
-6,313
-6% -$231K
INFY icon
403
Infosys
INFY
$48.4B
$3.42M 0.03%
247,978
-70,229
-22% -$877K
ARCT icon
404
Arcturus Therapeutics
ARCT
$168M
$3.42M 0.03%
79,720
– –
ATO icon
405
Atmos Energy
ATO
$29.1B
$3.41M 0.03%
35,653
-1,475
-4% -$147K
FCX icon
406
Freeport-McMoran
FCX
$91.2B
$3.39M 0.03%
216,549
-211,709
-49% -$3.05M
ARDX icon
407
Ardelyx
ARDX
$1.25B
$3.35M 0.03%
+637,643
New +$3.83M
SSRM icon
408
SSR Mining
SSRM
$5.54B
$3.33M 0.03%
+179,086
New +$3.81M
GPN icon
409
Global Payments
GPN
$23.8B
$3.32M 0.03%
18,697
-749
-4% -$130K
COF icon
410
Capital One
COF
$129B
$3.26M 0.03%
45,394
-16,583
-27% -$1.11M
TFC icon
411
Truist Financial
TFC
$63.5B
$3.26M 0.03%
85,598
-2,408
-3% -$90.7K
SLF icon
412
Sun Life Financial
SLF
$45.9B
$3.25M 0.03%
80,032
+28,433
+55% +$1.15M
ICE icon
413
Intercontinental Exchange
ICE
$87.7B
$3.25M 0.03%
32,432
-2,539
-7% -$250K
FISV
414
Fiserv Inc
FISV
$28.8B
$3.2M 0.03%
31,073
-2,395
-7% -$239K
PHM icon
415
Pultegroup
PHM
$24.5B
$3.18M 0.03%
68,662
-131,365
-66% -$5.62M
ADVM
416
DELISTED
Adverum Biotechnologies
ADVM
$3.13M 0.03%
30,358
+7,500
+33% +$1.12M
NIO icon
417
NIO
NIO
$12.1B
– –
0
– –
TTWO icon
418
Take-Two Interactive
TTWO
$46.3B
$3.1M 0.03%
18,758
-1,387
-7% -$225K
VRAY
419
DELISTED
ViewRay, Inc.
VRAY
$3.09M 0.03%
881,705
-33,899
-4% -$94.4K
PCAR icon
420
PACCAR
PCAR
$70.4B
$3.08M 0.03%
54,182
-1,596
-3% -$89.5K
AKRO
421
DELISTED
Akero Therapeutics
AKRO
$3.06M 0.03%
99,500
-58,500
-37% -$2.04M
DOW icon
422
Dow Inc
DOW
$21.7B
$3.04M 0.03%
64,559
-3,391
-5% -$152K
CYTK icon
423
Cytokinetics
CYTK
$10.9B
$3.04M 0.03%
+140,225
New +$3.28M
GM icon
424
General Motors
GM
$80B
$3.02M 0.03%
102,207
-3,626
-3% -$102K
SNY icon
425
Sanofi
SNY
$103B
$3.02M 0.03%
60,148
+8,916
+17% +$459K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.